Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NR2F6 |
| Upstream (Parents) |
|---|
| (<<) HR → NR2F6 |
| (<<) NR5A2 → NR2F6 |
| (<<) RFXAP → NR2F6 |
| (<<) SIX3 → NR2F6 |
| (<<) HOXA5 → NR2F6 |
| (<<) FOS → NR2F6 |
| (<<) TAL1 → NR2F6 |
| (<<) EGR3 → NR2F6 |
| (<<) HMX1 → NR2F6 |
| (<<) NFIX → NR2F6 |
| (<<) BATF3 → NR2F6 |
| (<<) ERG → NR2F6 |
| (<<) BHLHE40 → NR2F6 |
| (<<) NR2C1 → NR2F6 |
| Downstream (Children) |
|---|
| NR2F6 → NPAS1 (>>) |
| NR2F6 → MLL (>>) |
| NR2F6 → CLOCK (>>) |
| NR2F6 → THRB (>>) |
| NR2F6 → HSF4 (>>) |
| NR2F6 → PBX2 (>>) |
| NR2F6 → CREBBP (>>) |
